Developed based on a thorough review of the scientific evidence, NutraOrigin's Osteozol formula includes only ingredients with documented efficacy and safety, and contains no artificial colors, flavors or preservatives. The ingredients described below will give you a better understanding of how Osteozol strengthens, protects and builds your bones.*
Click to view Product Research
Coral Calcium
Coral calcium originates in fossilized coral reefs. More than just calcium, it is a whole mineral complex, delivering a full spectrum of 74 trace minerals naturally found in the ocean. Adding coral calcium to the diet may help to keep your mineral levels in balance for optimal health.*
Microcrystalline Hydroxyapatite
Microcrystalline hydroxyapatite compound (MCHC) is a well-absorbed form of calcium that has been reported in human studies to increase bone mass.* (1) Other studies suggest that supplementing with MCHC alleviates occasional back pain and may preserve bone density.* (2,3)
Calcium Citrate
Many studies indicate that high calcium intake - especially calcium citrate supplements with vitamin D - may help reduce the risk of osteoporosis in postmenopausal women, particularly when used in conjunction with proper diet and exercise.* (4-14)
Vitamin D
Vitamin D, essential for the growth and development of bones, (15) regulates calcium absorption.* Deficiencies of vitamin D are commonly found in individuals suffering from or at risk for osteoporosis.* (16-20) Vitamin D deficiency is more common than once thought, affecting 21-58% of American adolescents and adults (depending on age and gender). (21)
Zinc
Zinc is an important element found in every cell of the body. Over 300 enzymes need zinc to work correctly. Excess urinary zinc excretion may be correlated with poor bone health .* (22) Zinc enhances vitamin D activity, making sure that calcium gets absorbed.* (23)
Boron
Boron aids in metabolizing vitamins and minerals that build bone, including calcium, magnesium, copper and vitamin D.* One study found that boron supplementation reduced the amount of calcium post-menopausal women lost through urine.* (24) Other studies show that boron may also support joint function and mobility.* (25-26)
Copper
Copper plays an essential role in bone metabolism.* (27) Some researchers have suggested that copper insufficiency may negatively affect bone density.* (28-30) Excess amounts of zinc can deplete copper, so it's important to balance any zinc intake with the proper amount of copper. Research has found that using combinations of various trace minerals, including copper, can promote bone health.* (31)
Magnesium
Magnesium regulates calcium transport and thus is essential for the health, strength, and growth of bones.* (32) Magnesium is also necessary for the binding of calcium to tooth enamel, thereby suppressing tooth decay.* Higher magnesium intake is positively correlated with better bone mineral density.* (33)
Manganese
Found in higher concentrations in bones than anywhere else in the body, manganese is essential for the formation and stability of bone and cartilage.* (34) This mineral has been clinically demonstrated to support bone mineral density.* (27) It also helps toughen the connective tissue that holds bone together.* (35)
Strontium
Supplementation with strontium, a trace mineral, has been shown to increase bone formation and boost bone density overall in several studies.* (36-40) Two large double-blind, placebo-controlled studies, both lasting three years, determined that strontium protects bones from load-bearing stress.* (36,41)
Silicon
Silicon plays a role in the production of collagen, thus providing strength and flexibility to bones, teeth, tendons, ligaments, nails, skin, and cell walls and membranes.* Research in women suggests that silicon supplementation may increase bone mineral density.* (42) Additional studies in animals and humans point to its importance in bone formation, wound healing and the health of hair, skin and nails.* (43-46) A major observational study showed a direct relationship between silicon intake and bone strength.* (47)
L-Lysine
L-lysine is an essential amino acid, meaning it is important to health but not produced by the body. Research has shown that L-lysine increases calcium absorption, making it a powerful tool in supporting bone health.* (48,49) A human clinical trial found that L-lysine supplementation helps increase the absorption of calcium from the digestive tract and attenuate the loss of calcium in the urine.* (48)
Vitamin C
As a facilitator of collagen production, vitamin C may provide strength and flexibility to bones.* (Collagen I, the most abundant type of collagen in the body, is a key constituent of bone.) Observational research has found that higher intakes of vitamin C are associated with better joint health.* (49)
Vitamin K
Vitamin K plays a role in forming bone-mineralizing proteins.* Clinical studies show that vitamin K supplementation preserves bone mineral density and appears to work synergistically with vitamin D.* (50-52) One study of 72,000 women aged 38-63 found that those who had a higher vitamin K intake were more likely to enjoy better bone health than those with a lower intake.* (53)
B6, B12, and Folic Acid
Vitamin B12, together with vitamin B6 and folic acid, can help to lower levels of a potentially harmful amino acid called homocysteine. (54) Two new observational studies suggest that high homocysteine may negatively impact bone health. (55,56) An observational study in female adults showed that maintaining adequate levels of vitamin B12 may preserve bone mineral density of the hip.* (57) Another study, in Japanese adults, found that the combination of vitamin B12 and folate may protect the hip bone against load-bearing stress.* (58) A third study concluded that higher levels of serum vitamin B12 appear to be protective of bone.* (59)
Close window
- Durance RA, Parsons V, Atkins CJ. "Treatment of osteoporotic patients, a trial of calcium supplements (MCHC) and ashed bone." Clin Trials J (1973) 3:67-73.
- Pines A, et al. "Clinical trial of microcrystalline hydroxyapatite compound ('Ossopan') in the prevention of osteoporosis due to corticosteroid therapy." Curr Med Res Opin (1984) 8(10):734-42.
- Stellon A, et al. "Microcrystalline hydroxyapatite compound in prevention of bone loss in corticosteroid-treated patients with chronic active hepatitis." Postgrad Med J (1985) Sep;61(719):791-6.
- Reid IR. "The roles of calcium and vitamin D in the prevention of osteoporosis." Endocrinol Metab Clin North Am (1998) 27:389-98.
- Cumming RG. "Calcium intake and bone mass: a quantitative review of the evidence." Calcif Tissue Int (1990) 47:194-201.
- Dawson-Hughes B, et al. "A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women." N Engl J Med (1990) 323:878-83.
- Peacock M, et al. "Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60." J Clin Endocrinol Metab (2000) 85:3011-9.
- Prince RL. "Diet and the prevention of osteoporotic fractures." N Engl J Med (1997) 337:701-2.
- Shea B, et al. "Calcium supplementation on bone loss in postmenopausal women." Cochrane Database Syst Rev (2003) 4:CD004526.
- Porthouse J, et al. "Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care." BMJ (2005) 330:1003.Close window
- Avenell A, et al. "Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people: a randomised placebo-controlled trial." Lancet (2005) 365:1621-8.
- Prince RL, et al. "Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women." Arch Intern Med (2006) 166:869-75.
- Reid IR, et al. "Randomized controlled trial of calcium in healthy older women." Am J Med (2006) 119:777-85.
- Bolton-Smith C, et al. "A two-year randomized controlled trial of vitamin K(1) (phylloquinone) and vitamin D(3) Plus calcium on the bone health of older women." J Bone Miner Res (2007) Jan 23.
- Outila TA, Karkkainen MU, Lamberg-Allardt CJ. "Vitamin D status affects serum parathyroid hormone concentrations during winter in female adolescents: associations with forearm bone mineral density." Am J Clin Nutr (2001) Aug;74(2): 206-10.
- Villareal DT, et al. "Subclinical vitamin D deficiency in postmenopausal women with low vertebral bone mass." J Clin Endocrinol Metab (1991) 72(3):628-34.
- Rassouli A, Milanian I, Moslemi-Zadeh M. "Determination of serum 25-hydroxyvitamin D(3) levels in early postmenopausal Iranian women: relationship with bone mineral density." Bone (2001) Nov; 29(5):428-30.
- Mezquita-Raya P, et al. "Relation between vitamin D insufficiency, bone density, and bone metabolism in healthy postmenopausal women." J Bone Miner Res (2001) Aug;16(8):1408-15.
- Brot C, et al. "Vitamin D status and its adequacy in healthy Danish perimenopausal women: relationships to dietary intake, sun exposure and serum parathyroid hormone." Br J Nutr (2001) Aug;86(Suppl 1):S97-103.
- Grados F, et al. "Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation." J Clin Endocrinol Metab (2003) Nov;88(11):5175-9.Close window
- Looker AC, et al. "Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III." Bone (2002) 30:771-7.
- Relea P, et al. "Zinc, biochemical markers of nutrition, and type-I osteoporosis." Age Ageing (1995) 24:303-7.
- Lutz W, et al. "Zinc increases the activity of vitamin D-dependent promoters in osteoblasts." Biochem Biophys Res Commun (2000) Apr 29;271(1):1-7.
- Nielsen FH, et al. "Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women." FASEB (1987) 1:394-397.
- Newnham RE. "Essentiality of boron for healthy bones and joints." Environ Health Perspect (1994) Nov;102(Suppl 7):83-5.
- Travers RL, Rennie GC, Newnham RE. "Boron and arthritis: the results of a double-blind pilot study." J Nutr Med (1990) 1:127-32.
- Saltman PD, Strause LG. "The role of trace minerals in osteoporosis." J Am Coll Nutr (1993) 12:384-9.
- Strain JJ. "A reassessment of diet and osteoporosis - possible role for copper." Med Hypotheses (1988) Dec;27(4):333-8.
- Sorenson JR, et al. "Treatment of rheumatoid and degenerative diseases with copper complexes: A review with emphasis on copper-salicylate." Inflammation (1997) Sept;2(3):217-38.
- Klevay LM. "Lack of a recommended dietary allowance for copper may be hazardous to your health." J Am Coll Nutr (1998) Aug;17(4):322-6.Close window
- Strause L, et al. "Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals." J Nutr (1994) 124:1060-4.
- Stendig-Lindberg G, Tepper R, Leichter I. "Trabecular bone density in a two year controlled trial of peroral magnesium in osteoporosis." Magnes Res (1993) Jun:6(2):155-63.
- Angus RM, et al. "Dietary intake and bone mineral density." Bone Miner (1988) Jul;4(3):265-77.
- Freeland-Graves J. "Manganese: An essential nutrient for humans." Nutrition Today (1988) Dec:13-9.
- Leach RM Jr. "Role of manganese in mucopolysaccharide metabolism." Fed Proc (1971) 30(3):991-4.
- Reginster JY, et al. "Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Perpheral Osteoporosis (TROPOS) study." J Clin Endocrinol Metab (2005) 90(5):2816-22.
- Reginster JY, Meunier PJ. "Strontium ranelate phase 2 dose-ranging studies: PREVOS and STRATOS studies." Osteoporos Int (2003) 14 Suppl 3:S56-65.
- Reginster JY, Deroisy R, Jupsin I. "Strontium ranelate: a new paradigm in the treatment of osteoporosis." DrugsToday (Barc) (2003) 39:89-101.
- Reginster JY, et al. "Prevention of early postmenopausal bone loss by strontium ranelate: the randomized, two-year, double-masked, dose-ranging, placebo-controlled PREVOS trial." Osteoporos Int (2002) 13:925-31.
- Meunier PJ, et al. "Strontium ranelate: dose-dependent effects in established postmenopausal vertebral osteoporosis-a 2-year randomized placebo controlled trial." J Clin Endocrinol Metab (2002) 87:2060-6.Close window
- Meunier PJ, et al. "The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis." N Engl J Med (2004) 350:459-68.
- Eisinger J, et al. "Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: A retrospective study." Magnes Res (1993) Sept;6(3):247-9.
- Seaborn CD, Nielsen FH. "Silicon deprivation decreases collagen formation in wounds and bone, and ornithine transaminase enzyme activity in liver." Biol Trace Elem Res (2002) 89:251-61.
- Rico H, et al. "Effect of silicon supplement on osteopenia induced by ovariectomy in rats." Calcif Tissue Int (2000) 66:53-5.
- Carlisle EM. "Silicon as a trace nutrient." Sci Total Environ (1989) 73:95-106.
- Barel A, et al. "Effect of oral intake of choline-stabilized orthosilicic acid on skin, nails and hair in women with photodamaged skin." Arch Dermatol Res (2005) Oct;297(4):147-53.
- Jugdaohsingh R, et al. "Dietary silicon intake is positively associated with bone mineral density in men and premenopausal women of the Framingham Offspring cohort." J Bone Miner Res (2004) 19:297-307.
- Civitelli R, et al. "Dietary L-lysine and Calcium Metabolism in Humans." Nutrition (1992) Nov;8(6):400-5.
- McAlindon TE, et al. "Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis?" Arthitis Rheum. (1996) 39:648-656.
- Weber P. "Vitamin K and bone health." Nutrition (2001) Oct;17(10):880-7.Close window
- Shiraki M, et al. "Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis." J Bone Miner Res (2000) Mar;15(3):515-21.
- Iwamoto I, et al. "A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy." Maturitas (1999) Jan;31(2):161-4.
- Feskanich D, et al. "Vitamin K intake and hip fractures in women: a prospective study." Am J Clin Nutr (1999) Jan;69(1):74-9.
- Nakhoul F, et al. "Comparative study of response to treatment with supraphysiologic doses of B-vitamins in hyperhomocysteinemic hemodialysis patients." Isr Med Assoc J (2004) Apr;6(4):213-7.
- McLean RR, et al. "Homocysteine as a predictive factor for hip fracture in older persons." N Engl J Med (2004) 350:2042-9.
- Van Meurs JBJ, et al. "Homocysteine levels and the risk of osteoporotic fracture." N Eng J Med (2004) 350:2033-41.
- Stone KL, et al. "Low serum vitamin B-12 levels are associated with increased hip bone loss in older women: a prospective study." J Clin Endocrinol Metab (2004) Mar;89(3):1217-21.
- Uebelhart B, Rizzoli R. "Osteoporosis treatment." Rev Med Suisse (2006) Jan 4;2(47):47-51.
- Stone KL, et al. "Low serum vitamin B-12 levels are associated with increased hip bone loss in older women: A prospective study." J Clin Endocrinol Metab (2004) Mar;89(3): 1217-21.
Close window